Lumiera Health (TSXV:NHP.H) Net-Net Working Capital : C$-0.01 (As of Aug. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Lumiera Health Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Lumiera Health's Net-Net Working Capital for the quarter that ended in Aug. 2023 was C$-0.01.

The industry rank for Lumiera Health's Net-Net Working Capital or its related term are showing as below:

TSXV:NHP.H's Price-to-Net-Net-Working-Capital is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 6.74
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Lumiera Health Net-Net Working Capital Historical Data

The historical data trend for Lumiera Health's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumiera Health Net-Net Working Capital Chart

Lumiera Health Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Nov18

Nov19

Nov20

Nov21

Nov22

Net-Net Working Capital

Get a 7-Day Free Trial

0.01

-0.01

Lumiera Health Quarterly Data
	Sep18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Net-Net Working Capital	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-0.01	-0.01

Competitive Comparison of Lumiera Health's Net-Net Working Capital

For the Drug Manufacturers - Specialty & Generic subindustry, Lumiera Health's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumiera Health's Price-to-Net-Net-Working-Capital Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lumiera Health's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Lumiera Health's Price-to-Net-Net-Working-Capital falls into.

Lumiera Health Net-Net Working Capital Calculation

Lumiera Health's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Nov. 2022 is calculated as

	Net-Net Working Capital		(A: Nov. 2022 )
=	(Cash, Cash Equivalents, Marketable Securities	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.015	+	0.75 * 0.032	+	0.5 * 0.109	-	2.298
-	0	-	0)	/	169.965
=	-0.01

Lumiera Health's Net-Net Working Capital (NNWC) per share for the quarter that ended in Aug. 2023 is calculated as

	Net-Net Working Capital		(Q: Aug. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.013	+	0.75 * 0.027	+	0.5 * 0.082	-	1.947
-	0	-	0)	/	169.965
=	-0.01

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.

Lumiera Health (TSXV:NHP.H) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.

Lumiera Health Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Lumiera Health's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumiera Health (TSXV:NHP.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lumiera Health Inc (TSXV:NHP.H) » Definitions » Net-Net Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

4500 Kimber, Suite 26, Saint-Hubert, QC, CAN, J3Y 8K5

Website

https://www.lumiera.ca

Lumiera Health Inc is a natural health products company. The company is developing products focusing on the endocannabinoid system and providing treatments for chronic pain and inflammation.

Lumiera Health (TSXV:NHP.H) Headlines

No Headlines